New Topical Cannabis Cream, TopiCanna, Hits the Market

Posted by Laura Swartz

December 16, 2014 at 10:30 AM

This week, diversified life sciences company Tauriga Sciences, Inc. (TAUG-OTC) launched its first proprietary topical medicinal cannabis cream branded as TopiCanna and provided a corporate update. Highlights of the news are described below, and the complete press release is available here.

Read More

Topics: Tauriga

New Video Clip: Jeff Kraws Talks Antibiotic Resistance Forecasts and Impacts

Posted by Laura Swartz

December 15, 2014 at 12:51 PM

In the wake of a new report from the British government stating that antibiotic-resistant infections could kill 10 million people each year by the year 2050, senior pharmaceutical analyst Jeff Kraws of Crystal Research Associates sits down with host Akhtar Khan of Arise Xchange to discuss the report's projections and impacts of increasing drug resistance on the pharmaceutical industry and on consumers.

Read More

Topics: Crystal Research Associates

Chewable Pill to Help Treat Type 2 Diabetes Receives IND Approval

Posted by Laura Swartz

December 10, 2014 at 9:19 AM

This morning, pharmaceutical company Boston Therapeutics, Inc. (BTHE-OTC) reported that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) filing for BTI-320, a new generation of alpha glucosidase inhibitor that is designed to reduce post-meal elevation of blood glucose. BTI-320 is expected to be taken before meals and works in the gastrointestinal tract to block the enzymes that break down and release carbohydrates into the bloodstream as glucose. With an approved IND, the company plans to start a major clinical study of BTI-320 in the first quarter 2015, as detailed in Boston Therapeutics' press release below.

Read More

Topics: BTHE

NEW RESEARCH: Quarterly Update Available on Truett-Hurst (THST)

Posted by Laura Swartz

December 4, 2014 at 11:18 AM

Crystal Research Associates has released a 16-page Quarterly Update on Truett-Hurst, Inc. (THST-NASDAQ). Truett-Hurst is a wine sales, marketing, and production company specializing in $7.00 to $50.00 per bottle wines. The company is known for its quality and packaging innovations. Based in the Dry Creek and Russian River Valleys of Sonoma County, California, its product line includes over 30 wine brands. Truett-Hurst’s largest business segment is its retail exclusive label partnerships with major retailers, including Trader Joe’s, Safeway, and Total Wine & More. For retail exclusive label sales, the company combines its competitive grape sourcing and skill in wine making and production with its understanding of consumer trends and unique approach to creating wine bottles that stand out on the retail shelf. These wines are sold exclusively by a retailer (e.g., Safeway) under a retail exclusive brand. The company also produces four of its own wine brands, which are sold through U.S. and Canadian distributors. Truett-Hurst further capitalizes on several direct-to-consumer sales channels, such as tasting rooms at its California wineries, wine clubs, and online sales through The Wine Spies, LLC (www.thewinespies.com) (an Internet wine retailer specializing in limited offerings and other online offerings as well as flash sales).

Read More

Topics: Truett-Hurst

Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Topic